Evaluation of Blood and Cardiac Protein O-GlcNAcylation Levels in Cardiac Surgery in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 17
SponsorNantes University Hospital

About this trial

Cardiac surgery requires the use of extracorporeal circulation (ECC). Age-related differences in inflammatory response, the greater susceptibility of immature organ systems to injury and the larger ratio of extracorporeal circuitry to patient size make younger and smaller patients more vulnerable to organ injury. The main problem associated with ECC in neonates and infants is the duration of ECC due to heavier surgeries leading to a prolonged inflammatory state resulting in capillary leak syndrome, low cardiac output syndrome and organ dysfunction, resulting in higher morbidity and mortality. The means of limiting this inflammatory response remain limited. Future studies should aim to address new post-ECC prophylactic targets to improve myocardial and endothelial function. Cardiac metabolism is an important area of research because it plays a central role in maintaining cardiac function under stress. The study of O-GlcNAcylation could therefore be an interesting therapeutic target, given the beneficial role of its stimulation in acute stress situations, as demonstrated in sepsis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 0 to 17 years at the time of sampling

Children undergoing CEC for cardiac surgery

Signed bio-collection consent

Disqualifiers

Children with an infection

Children with fever

Children with an immune deficiency

Children with autoimmune disease

Trial population

Children aged between 0 and 17 undergoing cardiac surgery with extracorporeal circulation

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

300 Participants
are grouped into 1 trial group
Group A: Cardiac surgery with extracorporeal circulation

Trial outcomes

Primary outcomes

1

Evaluation of O-GlcNAcylation levels in cardiac surgery in children

To evaluate the evolution of O-GlcNAcylation levels in pre-per-post extracorporeal circulation in children

Time frame
From start of the surgery to 12 hours after start of the surgery

Secondary outcomes

1

Analysis of a potential link between O-GlcNAcylation levels and the prognosis of patients after cardiac surgery

To study the correlation between blood and cardiac O-GlcNAcylation levels and patient prognosis

Time frame
Up to 6 years after inclusion

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.